These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 20198769

  • 1. [Immunohistochemical profile of colorectal and ovarian carcinomas--examination with cytokeratin 7, cytokeratin 20, beta catenin and cDX 2].
    Porjazova E, Zaprjanov Z, Batashki I, Markova D, Milchev N.
    Akush Ginekol (Sofiia); 2009; 48(2):7-12. PubMed ID: 20198769
    [Abstract] [Full Text] [Related]

  • 2. [Differential diagnostic importance of immunochistochemistry applied at metastases of adenocarcinomas of the peritoneum].
    Porjazova E, Zaprjanov Z, Batashki I, Milchev N, Markova D.
    Akush Ginekol (Sofiia); 2009; 48(5):20-2. PubMed ID: 20198793
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7.
    Vang R, Gown AM, Wu LS, Barry TS, Wheeler DT, Yemelyanova A, Seidman JD, Ronnett BM.
    Mod Pathol; 2006 Nov; 19(11):1421-8. PubMed ID: 16980943
    [Abstract] [Full Text] [Related]

  • 4. Use of novel immunohistochemical markers expressed in colonic adenocarcinoma to distinguish primary ovarian tumors from metastatic colorectal carcinoma.
    Logani S, Oliva E, Arnell PM, Amin MB, Young RH.
    Mod Pathol; 2005 Jan; 18(1):19-25. PubMed ID: 15389251
    [Abstract] [Full Text] [Related]

  • 5. Differentiation of ovarian mucinous carcinoma and metastatic colorectal adenocarcinoma by immunostaining with beta-catenin.
    Chou YY, Jeng YM, Kao HL, Chen T, Mao TL, Lin MC.
    Histopathology; 2003 Aug; 43(2):151-6. PubMed ID: 12877730
    [Abstract] [Full Text] [Related]

  • 6. CDX-2 immunostaining in primary and secondary ovarian carcinomas.
    Tornillo L, Moch H, Diener PA, Lugli A, Singer G.
    J Clin Pathol; 2004 Jun; 57(6):641-3. PubMed ID: 15166272
    [Abstract] [Full Text] [Related]

  • 7. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody.
    Bayrak R, Haltas H, Yenidunya S.
    Diagn Pathol; 2012 Jan 23; 7():9. PubMed ID: 22268990
    [Abstract] [Full Text] [Related]

  • 8. The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries.
    Groisman GM, Meir A, Sabo E.
    Int J Gynecol Pathol; 2004 Jan 23; 23(1):52-7. PubMed ID: 14668551
    [Abstract] [Full Text] [Related]

  • 9. Women with undiagnosed colorectal adenocarcinomas presenting with ovarian metastases: clinicopathologic features and comparison with women having known colorectal adenocarcinomas and ovarian involvement.
    Judson K, McCormick C, Vang R, Yemelyanova AV, Wu LS, Bristow RE, Ronnett BM.
    Int J Gynecol Pathol; 2008 Apr 23; 27(2):182-90. PubMed ID: 18317225
    [Abstract] [Full Text] [Related]

  • 10. Primary cervical adenocarcinoma with intestinal differentiation and colonic carcinoma metastatic to cervix: an investigation using Cdx-2 and a limited immunohistochemical panel.
    Raspollini MR, Baroni G, Taddei A, Taddei GL.
    Arch Pathol Lab Med; 2003 Dec 23; 127(12):1586-90. PubMed ID: 14632574
    [Abstract] [Full Text] [Related]

  • 11. The usefulness of CDX-2 for differentiating primary and metastatic ovarian carcinoma: an immunohistochemical study using a tissue microarray.
    Kim MJ.
    J Korean Med Sci; 2005 Aug 23; 20(4):643-8. PubMed ID: 16100458
    [Abstract] [Full Text] [Related]

  • 12. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.
    Osunkoya AO, Epstein JI.
    Am J Surg Pathol; 2007 Sep 23; 31(9):1323-9. PubMed ID: 17721186
    [Abstract] [Full Text] [Related]

  • 13. CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs.
    Barbareschi M, Murer B, Colby TV, Chilosi M, Macri E, Loda M, Doglioni C.
    Am J Surg Pathol; 2003 Feb 23; 27(2):141-9. PubMed ID: 12548159
    [Abstract] [Full Text] [Related]

  • 14. Identifying colorectal metastases in liver biopsies: the novel CDX2 antibody is less specific than the cytokeratin 20+/7- phenotype.
    Tot T.
    Med Sci Monit; 2004 May 23; 10(5):BR139-43. PubMed ID: 15114262
    [Abstract] [Full Text] [Related]

  • 15. Combined immunohistochemistry of beta-catenin, cytokeratin 7, and cytokeratin 20 is useful in discriminating primary lung adenocarcinomas from metastatic colorectal cancer.
    Ikeda S, Fujimori M, Shibata S, Okajima M, Ishizaki Y, Kurihara T, Miyata Y, Iseki M, Shimizu Y, Tokumoto N, Ozaki S, Asahara T.
    BMC Cancer; 2006 Feb 02; 6():31. PubMed ID: 16451736
    [Abstract] [Full Text] [Related]

  • 16. CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma.
    Shin JH, Bae JH, Lee A, Jung CK, Yim HW, Park JS, Lee KY.
    Jpn J Clin Oncol; 2010 Mar 02; 40(3):208-13. PubMed ID: 19926591
    [Abstract] [Full Text] [Related]

  • 17. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type.
    Moh M, Krings G, Ates D, Aysal A, Kim GE, Rabban JT.
    Am J Surg Pathol; 2016 Mar 02; 40(3):419-32. PubMed ID: 26551622
    [Abstract] [Full Text] [Related]

  • 18. Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma.
    Saad RS, Cho P, Silverman JF, Liu Y.
    Am J Clin Pathol; 2004 Sep 02; 122(3):421-7. PubMed ID: 15362373
    [Abstract] [Full Text] [Related]

  • 19. Immunoprofile of adenocarcinomas of the endometrium, endocervix, and ovary with mucinous differentiation.
    Park KJ, Bramlage MP, Ellenson LH, Pirog EC.
    Appl Immunohistochem Mol Morphol; 2009 Jan 02; 17(1):8-11. PubMed ID: 18776815
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder.
    Raspollini MR, Nesi G, Baroni G, Girardi LR, Taddei GL.
    Appl Immunohistochem Mol Morphol; 2005 Dec 02; 13(4):358-62. PubMed ID: 16280666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.